These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15485337)

  • 1. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
    Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
    Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.
    Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M
    J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats.
    Arricau-Bouvery N; Souriau A; Bodier C; Dufour P; Rousset E; Rodolakis A
    Vaccine; 2005 Aug; 23(35):4392-402. PubMed ID: 16005747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxiella burnetii: host and bacterial responses to infection.
    Waag DM
    Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
    Shannon JG; Heinzen RA
    Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine.
    Guatteo R; Seegers H; Joly A; Beaudeau F
    Vaccine; 2008 Aug; 26(34):4320-8. PubMed ID: 18586060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ; Ruble DL; Zaucha GM; Jaax GP; Waag DM
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in Q fever.
    Kazár J
    Acta Virol; 1988 Jul; 32(4):358-68. PubMed ID: 2903642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation.
    de Cremoux R; Rousset E; Touratier A; Audusseau G; Nicollet P; Ribaud D; David V; Le Pape M
    FEMS Immunol Med Microbiol; 2012 Feb; 64(1):104-6. PubMed ID: 22066485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.
    Crăcea E; Dumitrescu-Constantinescu S; Botez D; Ioanid L
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):413-8. PubMed ID: 910580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term immune responses to Coxiella burnetii after vaccination.
    Kersh GJ; Fitzpatrick KA; Self JS; Biggerstaff BJ; Massung RF
    Clin Vaccine Immunol; 2013 Feb; 20(2):129-33. PubMed ID: 23192629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.
    Kazár J; Gajdosová E; Kovácová E; Valková D
    Acta Virol; 1995 Dec; 39(5-6):243-9. PubMed ID: 8722292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees.
    Gajdosová E; Brezina R
    Acta Virol; 1989 Sep; 33(5):474-81. PubMed ID: 2576587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii.
    Li Q; Niu D; Wen B; Chen M; Qiu L; Zhang J
    Ann N Y Acad Sci; 2005 Dec; 1063():130-42. PubMed ID: 16481504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxiella burnetii infection.
    Kazar J
    Ann N Y Acad Sci; 2005 Dec; 1063():105-14. PubMed ID: 16481501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
    Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.